JFL Life Sciences Limited IPO Detail
Incorporated in 2010, JFL Life Sciences Limited is engaged in the business of manufacturing of pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).
The company's sales strategy is to sell the products in bulk to pharmaceutical marketers and traders who in turn provide the channel for sales to customers. JFL Life Sciences Limited has a market presence in PAN India and JFL's products are supplied to 10 developed and developing countries throughout the World.
JFL Life Sciences Limited exports products to African, Middle Eastern, and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing a particular product. Few of our products are also registered with Ukraine, Uzbekistan, and Kazakhstan (CIS countries) through merchants.
JFL has two manufacturing units (on lease) in Gujarat.
Competitive Strength :
- Product registration
- Experienced management and dedicated employee base
- Quality assurance
- Quality & Brand strength
Company Promoters
Smiral Ashwinkumar Patel and Tejal Smiral Patel are the company promoters.IPO Details
| IPO Opening Date | Aug 25, 2022 |
| IPO Closing Date | Aug 30, 2022 |
| Issue Type | Fixed Price Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹61 per equity share |
| Market Lot | 2000 Shares |
| Min Order Quantity | 2000 Shares |
| Listing At | NSE SME |
| Issue Size | ₹18.17 Cr |
| Fresh Issue | 2,978,000 shares of ₹10 (aggregating up to ₹18.17 Cr) |
| Offer for Sale | - |
| Retail Portion | 50% |
IPO Subscription (Bidding Detail)
| AS On | QIB | SHNI | BHNI | NII | RII | TOTAL |
|---|---|---|---|---|---|---|
| Day 1 | - | - | 0.24x | 0.75x | 0.49x | |
| Day 2 | - | - | 0.24x | 0.79x | 0.51x | |
| Day 3 | - | - | 6.19x | 11.66x | 8.93x |
IPO Tentative Timetable
The JFL Life Sciences Limited IPO open date is Aug 25, 2022, and the close date is Aug 30, 2022. The issue may list on Sep 08, 2022.
| IPO Open Date | Aug 25, 2022 |
| IPO Close Date | Aug 30, 2022 |
| Basis of Allotment Date | Sep 05, 2022 |
| Initiation of Refunds | Sep 06, 2022 |
| Credit of Shares to Demat Account | Sep 07, 2022 |
| IPO Listing Date | Sep 08, 2022 |
IPO Lot Size
The JFL Life Sciences Limited IPO market lot size is 2000 shares. A retail-individual investor can apply for up to 1 lots (2000 shares or ₹122000).
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 2000 | ₹122000 |
| Maximum | 1 | 2000 | ₹122000 |
IPO Promoter Holding
| Pre Issue Share Holding | 92.52% |
| Post Issue Share Holding | 67.47% |
Company Financials:
For the year/period ended (₹ in Lakhs)
| Financial Year | Total Assets | Total Revenue | Profit After Tax |
|---|---|---|---|
| 31-Mar-20 | 2432.59 | 3020.41 | 36.04 |
| 31-Mar-21 | 2900.69 | 3286.89 | 54.21 |
| 28-Feb-22 | 3662.86 | 2563.06 | 253.28 |
Objects of the Issue:
The Company proposes to utilize the funds which are being raised through this Issue ("Net Proceeds") towards the following objects:
- Repayment of secured and unsecured loans.
- Funding the working capital requirements of the company.
- General Corporate Purposes
JFL Life Sciences Limited IPO Registrar:
KFin Technologies Limited
JFL Life Sciences Limited IPO Lead Manager(s):
GYR Capital Advisors Limited (Past IPO Performance)
Company Contact Information:
JFL Life Sciences Limited
309, Satyam Mall, Opp. Saman Complex, Nr. Vishweshwar Mahadev Mandir Settelite,
Ahmedabad
Gujarat
